Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$57.1M |
| 2 |
Veralto
VLTO
|
+$54.6M |
| 3 |
Newmont
NEM
|
+$40.4M |
| 4 |
Vertiv
VRT
|
+$17.2M |
| 5 |
Webster Financial
WBS
|
+$14.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$314M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$237M |
| 3 |
Microsoft
MSFT
|
+$231M |
| 4 |
VMW
VMware, Inc
VMW
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.88% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.38% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Gulfport Energy Corp
GPOR
$3.01B
| $3.18M | ﹤0.01% |
23,900
-500
| -2% | -$64.4K |
|
1577
Upbound Group
UPBD
$1.15B
| $3.18M | ﹤0.01% |
93,700
-10,800
| -10% | -$322K |
|
|
PRO
1578
DELISTED
PROS Holdings
PRO
| $3.18M | ﹤0.01% |
82,000
-9,200
| -10% | -$331K |
|
|
CPRX
1579
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.18M | ﹤0.01% |
189,100
-33,400
| -15% | -$457K |
|
|
ACLX
1580
DELISTED
Arcellx
ACLX
| $3.17M | ﹤0.01% |
57,200
-6,100
| -10% | -$275K |
|
1581
Vericel Corp
VCEL
$2.28B
| $3.17M | ﹤0.01% |
89,100
-10,200
| -10% | -$355K |
|
1582
JELD-WEN Holding
JELD
$170M
| $3.17M | ﹤0.01% |
167,900
-18,900
| -10% | -$281K |
|
1583
Stewart Information Services
STC
$2.07B
| $3.17M | ﹤0.01% |
53,900
-5,800
| -10% | -$275K |
|
1584
Ironwood Pharmaceuticals
IRWD
$674M
| $3.17M | ﹤0.01% |
276,700
-30,600
| -10% | -$303K |
|
1585
La-Z-Boy
LZB
$1.67B
| $3.13M | ﹤0.01% |
84,900
-10,300
| -11% | -$332K |
|
|
NVEE
1586
DELISTED
NV5 Global
NVEE
| $3.13M | ﹤0.01% |
112,800
-11,600
| -9% | -$295K |
|
1587
Newmark Group
NMRK
$2.77B
| $3.13M | ﹤0.01% |
285,307
-34,700
| -11% | -$262K |
|
|
VGR
1588
DELISTED
Vector Group Ltd.
VGR
| $3.12M | ﹤0.01% |
276,573
-32,000
| -10% | -$347K |
|
1589
NETSCOUT
NTCT
$2.89B
| $3.12M | ﹤0.01% |
142,128
-14,500
| -9% | -$325K |
|
1590
Viking Therapeutics
VKTX
$3.84B
| $3.12M | ﹤0.01% |
167,600
-29,900
| -15% | -$391K |
|
1591
First Commonwealth Financial
FCF
$2.19B
| $3.12M | ﹤0.01% |
201,800
-24,400
| -11% | -$326K |
|
1592
Supernus Pharmaceuticals
SUPN
$2.74B
| $3.11M | ﹤0.01% |
107,600
-12,100
| -10% | -$321K |
|
|
ARI
1593
Apollo Commercial Real Estate
ARI
$886M
| $3.11M | ﹤0.01% |
264,639
-30,500
| -10% | -$327K |
|
|
B
1594
DELISTED
Barnes Group Inc.
B
| $3.09M | ﹤0.01% |
94,700
-11,000
| -10% | -$314K |
|
1595
Myriad Genetics
MYGN
$303M
| $3.09M | ﹤0.01% |
161,400
-17,900
| -10% | -$310K |
|
1596
Denison Mines
DNN
$2.95B
| $3.09M | ﹤0.01% |
1,760,700
-80,900
| -4% | -$135K |
|
1597
Levi Strauss
LEVI
$8.63B
| $3.09M | ﹤0.01% |
186,600
-21,500
| -10% | -$319K |
|
1598
Pacira BioSciences
PCRX
$924M
| $3.08M | ﹤0.01% |
91,400
-9,700
| -10% | -$284K |
|
1599
Oxford Industries
OXM
$542M
| $3.08M | ﹤0.01% |
30,800
-3,800
| -11% | -$353K |
|
1600
Syndax Pharmaceuticals
SNDX
$1.7B
| $3.08M | ﹤0.01% |
142,400
+21,400
| +18% | +$329K |
|
Similar funds
Swiss National Bank's Q4 2023 Portfolio in Review
As of Q4 2023, Swiss National Bank held 2,646 positions worth $136B, up 6.9% from $127B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank withdrew a net $4.96B in Q4 2023, closing 112 positions and reducing 2,341 holdings. Its most notable exit was Activision Blizzard, an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Veralto worth $60.2M.
- Swiss National Bank's largest Q4 2023 buy was Veralto: 731,669 shares worth $60.2M.
- Swiss National Bank added most to Broadcom in Q4 2023, an estimated $57.1M increase.
- Swiss National Bank's biggest Q4 2023 reduction was Apple, cutting an estimated $314M.
- Swiss National Bank fully exited Activision Blizzard in Q4 2023, selling an estimated $237M.
- Swiss National Bank's ten largest holdings make up 28% of its $136B portfolio in Q4 2023.
- Swiss National Bank opened 38 new positions and closed 112 in Q4 2023.
- Swiss National Bank's portfolio value rose 6.9% quarter-over-quarter to $136B.
Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.